AI, biomarkers, and novel oncology modalities are driving evolution in biopharma pipelines, according to Nmblr CEO Janice MacLennan.
Janice MacLennan
Advertisement
Janice MacLennan is a senior strategy consultant to Big Pharma and the founder and CEO of Nmblr.
Articles by Janice MacLennan
Janice MacLennan, CEO of Nmblr, notes how AI is transforming biopharma R&D and market access, forcing teams to prove value beyond science and redesign work around human strengths.
Advertisement
Latest Updated Articles
Advertisement
Advertisement